While the recently published GEMM of RMS based on expression of YAPS127A in activated satellite cells yielded eRMS [17], both an oncogenic Kras-driven GEMM of RMS [9] and the current cell-based model resulted in a spectrum of tumor morphologies, from embryonal to pleomorphic RMS. Here, KRAS is linked to neoplasm.